Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Elite Pharms Inc
(OP:
ELTP
)
0.3695
-0.0006 (-0.16%)
Streaming Delayed Price
Updated: 10:02 AM EDT, Jun 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Elite Pharms Inc
< Previous
1
2
3
Next >
7 Penny Stocks With Promising Potential Catalysts in 2024
↗
November 09, 2023
Explore these top seven promising penny stocks set to soar as year-end approaches, offering stellar long-term upside ahead.
Via
InvestorPlace
Q4 Stock Predictions: 7 Penny Stocks Ready to Roar Into 2024
↗
October 09, 2023
When it comes to stocks predictions for the current quarter, these seven penny stocks to buy could start or continue to crush it.
Via
InvestorPlace
Elite Pharmaceuticals Files ANDA with US FDA to Market Opiate Analgesic Product
September 25, 2023
Via
ACCESSWIRE
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
September 07, 2023
Via
ACCESSWIRE
7 Up-and-Coming Penny Stocks to Put on Your Must-Buy List
↗
September 04, 2023
These seven up-and-coming penny stocks represent strong growth opportunities, and all sport reasonable valuations.
Via
InvestorPlace
Elite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024 ended June 30, 2023 and Provides Conference Call Information
August 14, 2023
Via
ACCESSWIRE
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2024 Financial Results on August 15, 2023
August 09, 2023
Via
ACCESSWIRE
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call Information
June 29, 2023
Via
ACCESSWIRE
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
August 28, 2023
Via
ACCESSWIRE
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2023 Financial Results on June 30, 2023
June 22, 2023
Via
ACCESSWIRE
7 OTC Stocks to Buy With Boatloads of Potential
↗
June 07, 2023
A mix of value and growth plays, risk-tolerant investors should consider these seven OTC stocks with high potential.
Via
InvestorPlace
Elite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial Officer
May 03, 2023
Via
ACCESSWIRE
Elite Pharmaceuticals Files ANDA with US FDA to Market Antimetabolite Product
April 20, 2023
Via
ACCESSWIRE
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Information
February 14, 2023
Via
ACCESSWIRE
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2023 Ended September 30, 2022 and Provides Conference Call Information
November 15, 2022
Via
ACCESSWIRE
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
November 02, 2022
Via
ACCESSWIRE
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2023 ended June 30, 2022, and Provides Conference Call Information
August 15, 2022
Via
ACCESSWIRE
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
February 07, 2023
Via
ACCESSWIRE
Elite Pharmaceuticals Files ANDA with US FDA to Market Dopamine Agonist
December 22, 2022
Via
ACCESSWIRE
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2023 Financial Results on November 15, 2022
November 08, 2022
Via
ACCESSWIRE
The 7 Best Penny Stocks for 10 Cents or Less
↗
September 19, 2022
If you are active in OTC stocks, and have a high risk appetite, consider these 7 penny stocks for 10 cents or less.
Via
InvestorPlace
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2023 Financial Results on August 16, 2022
August 11, 2022
Via
ACCESSWIRE
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2022 and Provides Conference Call Information
June 29, 2022
Conference Call Scheduled for Thursday, June 30 at 11:30 AM EDT
From
Elite Pharmaceuticals, Inc.
Via
AccessWire
Elite Pharmaceuticals Receives FDA Approval for Generic Sabril(R)
June 29, 2022
NORTHVALE, NJ / ACCESSWIRE / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced...
From
Elite Pharmaceuticals, Inc.
Via
AccessWire
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2022 Financial Results on June 30, 2022
June 23, 2022
Financials for Fiscal Year 2022 Ended March 31, 2022 will be released on June 29, 2022
From
Elite Pharmaceuticals, Inc.
Via
AccessWire
Elite Pharmaceuticals, Inc. Appoints Robert Chen as Chief Financial Officer
May 11, 2022
NORTHVALE, NJ / ACCESSWIRE / May 11, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic products,...
From
Elite Pharmaceuticals, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Elite Pharmaceuticals and Praxgen Pharmaceuticals Receive FDA Approval for Generic Doxycycline
April 04, 2022
NORTHVALE, NJ / ACCESSWIRE / April 4, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced...
From
Elite Pharmaceuticals, Inc.
Via
AccessWire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year Ended December 31, 2021 and Provides Conference Call Information
February 14, 2022
Conference Call Scheduled for Tuesday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty...
From
Elite Pharmaceuticals, Inc.
Via
AccessWire
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2022 Financial Results on February 15, 2022
February 09, 2022
Financials for Third Quarter Fiscal Year 2022 Ended December 31, 2021 will be released February 14, 2022 NORTHVALE, NJ / ACCESSWIRE / February 9, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the...
From
Elite Pharmaceuticals, Inc.
Via
AccessWire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year Ended September 30, 2021 and Provides Conference Call Information
November 15, 2021
Conference Call Scheduled for Tuesday, November 16th at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / November 15, 2021 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty...
From
Elite Pharmaceuticals, Inc.
Via
AccessWire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
